Last reviewed 2026-06-11 · How we verify

diseases other than human smallpox disease — Treatment Landscape & Competitive Intelligence

diseases other than human smallpox disease (disease) competitive landscape: 1 marketed treatments tracked, 0 Phase 3 candidates, 0 Phase 2 candidates. Recent regulatory actions and upcoming PDUFA dates across the entire treatment set.

Marketed treatment landscape

Approved drugs treating diseases other than human smallpox disease, deduplicated by molecule. See the full disease page for line-of-therapy detail.

Phase 3 pipeline

No Phase 3 pipeline candidates tracked.

Phase 2 pipeline

No Phase 2 pipeline candidates tracked.

Recent regulatory actions (last 90 days)

No regulatory actions in the last 90 days for this treatment set.

Upcoming PDUFA dates (next 180 days)

No PDUFA dates in the next 180 days for this treatment set.

Sponsor landscape

1. Emergent Biodefense · 1 drug in diseases other than human smallpox disease

Subscribe to ongoing alerts

Every new regulatory action, PDUFA date, or trial completion in diseases other than human smallpox disease:

• diseases other than human smallpox disease treatment updates — RSS
• diseases other than human smallpox disease treatment updates — Atom
• diseases other than human smallpox disease treatment updates — JSON

Cite this brief

Drug Landscape (2026). diseases other than human smallpox disease — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/diseases-other-than-human-smallpox-disease. Accessed 2026-06-11.

Related

• diseases other than human smallpox disease full disease profile — treatment pathway, diagnostics, guidelines
• Browse all CI briefs
• Build a custom feed

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing